Covance
Covance, a prominent global contract research organisation (CRO), is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1997, Covance has established itself as a leader in drug development and commercialisation services, providing comprehensive solutions that span preclinical and clinical research. The company offers a unique suite of services, including laboratory testing, clinical trial management, and regulatory consulting, tailored to meet the diverse needs of pharmaceutical and biotechnology clients. Covance's commitment to innovation and quality has positioned it as a trusted partner in the industry, with notable achievements in accelerating drug development timelines and enhancing patient safety. With a strong market presence, Covance continues to drive advancements in the life sciences sector, making significant contributions to the development of new therapies.
DitchCarbon Score
How does Covance's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Covance's score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Covance's reported carbon emissions
As of 2022, Covance has demonstrated a commitment to reducing its carbon emissions, with a reported carbon intensity of approximately 8,700 kg CO2e per full-time equivalent (FTE). This reflects a significant decrease from previous years, with carbon intensity figures of about 9,500 kg CO2e per FTE in 2021 and 9,700 kg CO2e per FTE in 2020. While specific reduction targets or initiatives have not been disclosed, the company is actively monitoring its carbon footprint, particularly in Scope 1 and 2 emissions. The trend indicates a positive trajectory towards sustainability, aligning with industry standards for climate action. Covance's efforts contribute to broader climate commitments within the scientific and healthcare sectors, emphasising the importance of reducing greenhouse gas emissions for environmental stewardship.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Covance is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
